Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis

Targeting of estrogen receptor is commonly used as a first-line treatment for hormone-positive breast cancer patients, and is considered as a keystone of systemic cancer therapy. Likewise, HER2-targeted therapy significantly improved the survival of HER2-positive breast cancer patients, indicating t...

Full description

Bibliographic Details

Published in:	Biochemical Society transactions Vol. 48; no. 2; p. 657
Main Author:	Lev, Sima
Format:	Journal Article
Language:	English
Published:	England 29.04.2020
Subjects:	Animals Cell Line, Tumor Cell Membrane - metabolism Drug Resistance, Neoplasm ErbB Receptors - metabolism Female Humans Molecular Targeted Therapy Oncogenes Transcriptome Triple Negative Breast Neoplasms - drug therapy Triple Negative Breast Neoplasms - metabolism EGFR drug resistance target therapy
ISSN:	1470-8752, 1470-8752
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!